🔴 Iovance Biotherapeutics is trading 4.2% down today as oil prices top $100

Iovance Biotherapeutics is trading 4.2% down now at $8.34 amid broad market weakness, elevated oil prices above $100 and geopolitical tensions.

• The Nasdaq is down 0.62%, while the S&P 500 is down 0.42%.
• No clear September 9, 2026 company-specific catalyst was identified.
• Recent company updates remain positive, including August 6 revenue growth and FDA Fast Track news.